- Saffelberg Investments
- 7 apr 2020
- 1 minuten om te lezen
Bijgewerkt op: 9 apr 2020
Liège, 30 March 2012 - Uteron Pharma successfully completed a 14 million EUR capital increase. This new equity round enables Uteron Pharma to further finance its strong growth ambitions as a specialist in female healthcare.
Comments